February 17, 2022
Article
A surgical oncologist honors an admirable doctor in the field who refuses to falter in the face of challenges in order to do exhaust every opportunity possible to improve the lives of patients with metastatic breast cancer.
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC